BEIJING: China's Shenzhen Kangtai Biological Products said on Tuesday (Feb 2) it has completed a facility designed to be able … [Read more...] about AstraZeneca’s China partner expects to be able to make 400 million COVID-19 vaccine doses a year
400
Moderna has $400 million in deposits for Covid-19 vaccine
The biotech, which has received funding from the United States' Operation Warp Speed program, also said it had about $400 … [Read more...] about Moderna has $400 million in deposits for Covid-19 vaccine